Gilead Sciences, Inc (GILD) Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

Newsdesk: